SARC-F and other screening tests for sarcopenia

Area of Science:

• Gerontology and Geriatric Medicine
• Musculoskeletal Health
• Public Health Screening

Background:

• Sarcopenia screening is vital for managing its prevalence and adverse outcomes.
• The SARC-F questionnaire is a commonly recommended screening tool.
• Existing tools like SARC-F have limitations in sensitivity for sarcopenia detection.

Purpose of the Study:

• To review recent evidence on the SARC-F screening tool for sarcopenia.
• To summarize studies on alternative and novel sarcopenia screening instruments.
• To evaluate the efficacy and potential of various screening tools for sarcopenia.

Main Methods:

• Systematic review and meta-analysis of recent studies on sarcopenia screening tools.
• Analysis of modifications to the SARC-F tool, including cut-off adjustments and added items.
• Investigation of newly developed and repurposed screening tests for sarcopenia.

Main Results:

• SARC-F demonstrates moderate-to-high specificity but low-to-moderate sensitivity for sarcopenia.
• Modifications to SARC-F, such as lower cut-offs or added items, can enhance its screening efficacy.
• Newer tools like Taiwan Risk Score, SarSA-Mod, SARQoL, and fracture risk tools show comparable or superior performance to SARC-F.

Conclusions:

• While SARC-F is recommended, its low sensitivity necessitates exploring alternative screening methods.
• Optimizing SARC-F and utilizing novel or repurposed tools can improve sarcopenia and frailty screening.
• Further validation of new screening tools in diverse populations and settings is required.